Logotype for Krystal Biotech Inc

Krystal Biotech (KRYS) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Krystal Biotech Inc

Proxy filing summary

3 Apr, 2026

Voting matters and shareholder proposals

  • Election of two Class III directors: Krish S. Krishnan and Christopher Mason, with board recommendation to vote in favor.

  • Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, recommended for approval.

  • Advisory approval of named executive officer compensation, with board recommendation to vote in favor.

  • Approval of Non-Employee Director Compensation Policy, recommended by the board.

  • Provision for other business to be addressed as may properly come before the meeting.

Board of directors and corporate governance

  • Nominees for Class III director positions are Krish S. Krishnan and Christopher Mason.

Executive compensation and say-on-pay

  • Advisory vote on the compensation of named executive officers is included as a proposal.

  • Separate proposal to approve the Non-Employee Director Compensation Policy.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more